Product image of Maxilin (Clarithromycin) supplied by GNH India

Maxilin

Active Ingredient:
Clarithromycin
Origin:
EU

Maxilin (Clarithromycin)

Clarithromycin, the active ingredient in Maxilin, is a macrolide antibiotic presented as an intravenous formulation for intravenous use. It treats a range of bacterial infections in both adult and pediatric patients as prescribed by a healthcare professional.

GNH India supplies Maxilin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Anfarm Hellas Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Clarithromycin is a macrolide antibiotic used to treat infections caused by susceptible bacteria across several organ systems.

  • Community‑acquired pneumonia: effective against typical and atypical pathogens, helping resolve lung infection.
  • Skin and soft‑tissue infections: reduces bacterial load in cellulitis, erysipelas and wound infections.
  • Sinusitis and otitis media: alleviates symptoms by targeting common respiratory pathogens.
  • Helicobacter pylori eradication: used as part of combination therapy to eliminate the bacterium.
  • Atypical mycobacterial infections: assists in managing infections caused by non‑tuberculous mycobacteria.

How It Works

  • Clarithromycin binds to the 50S subunit of bacterial ribosomes, blocking the translocation step of protein synthesis. This inhibition prevents the formation of essential proteins, exerting a bacteriostatic effect against susceptible Gram‑positive, Gram‑negative and atypical organisms.

Side Effects

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Diarrhea: loose stools, occasionally watery.
  • Abdominal pain: cramping or discomfort.
  • Altered taste: metallic or bitter sensation.
  • Headache: mild to moderate intensity.
  • Elevated liver enzymes: mild, transient increase.

Serious or Rare Side Effects

  • Severe allergic reactions: rash, angioedema, anaphylaxis.
  • Clostridioides difficile colitis: severe diarrhea with abdominal pain.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Hepatic failure: jaundice, elevated bilirubin.
  • Cardiac arrhythmias: ventricular tachycardia or fibrillation.
  • Stevens‑Johnson syndrome: severe skin and mucous membrane involvement.

Precautions & Warnings

When prescribing clarithromycin, clinicians should consider several safety measures.

  • Assess renal function: adjust therapy in patients with significant impairment.
  • Monitor liver enzymes: watch for signs of hepatotoxicity during treatment.
  • Check cardiac status: avoid in patients with known QT prolongation or arrhythmias.
  • Avoid use in patients with macrolide hypersensitivity: risk of severe hypersensitivity reactions.
  • Use caution in pregnancy: limited data, prescribe only if benefits outweigh potential risks.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Clarithromycin interacts with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid)

  • Erythromycin: additive QT‑prolongation risk.
  • Cisapride: may cause serious cardiac events.
  • Theophylline: increased plasma concentrations leading to toxicity.
  • Warfarin: enhanced anticoagulant effect, risk of bleeding.
  • Statins (lovastatin, simvastatin): heightened risk of myopathy.

Moderate Interactions (Monitor Closely)

  • Carbamazepine: reduces clarithromycin levels, may diminish efficacy.
  • Rifampin: induces metabolism, decreasing clarithromycin exposure.
  • Oral contraceptives: may lower hormonal effectiveness, advise backup contraception.

Frequently Asked Questions

Maxilin contains clarithromycin, a macrolide antibiotic indicated for the treatment of various bacterial infections such as community‑acquired pneumonia, skin and soft‑tissue infections, sinusitis, otitis media, and as part of Helicobacter pylori eradication regimens.

Clarithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking the translocation step. This action stops the production of essential proteins, resulting in a bacteriostatic effect against susceptible organisms.

The dosage of Maxilin is determined by the prescribing clinician based on the specific infection, patient weight, renal and hepatic function, and local guidelines. Only a qualified healthcare professional should set the appropriate regimen.

Safety data for clarithromycin in pregnancy and lactation are limited. It should be used only when the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified prescriber.

To order Maxilin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Clarithromycin offers a broader spectrum against atypical pathogens and better tissue penetration compared with older macrolides such as erythromycin. It also has a more favorable dosing schedule and fewer drug‑food interactions, though clinicians must still consider its interaction profile and QT‑prolongation risk.

Maxilin should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain stability.

Maxilin is administered intravenously by a healthcare professional. The infusion rate and duration are determined by the prescriber, typically given over 30 minutes to 1 hour, depending on the clinical situation and patient tolerance.

Serious risks include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated colitis, QT interval prolongation leading to arrhythmias, and hepatic dysfunction. Patients should be monitored for signs of these events, especially if they have pre‑existing cardiac or liver conditions.

Maxilin is contraindicated in patients with a known hypersensitivity to clarithromycin or other macrolides. It should also be avoided in individuals with a history of significant QT prolongation, ventricular arrhythmias, or those taking medications that strongly interact and cannot be safely managed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clarithromycin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT